Oxaliplatin Injection for Intravenous Use
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
April 2016
WARNINGS AND PRECAUTIONS
Severe Neutropenia
Grade 3 or 4 neutropenia occurred in 41 to 44% of patients with...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts